Approval · Notice of Compliance 2114 · 2001
FLEXERIL: Notice of Compliance 2114
Issued August 24, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2114
- Date
- August 24, 2001
- Company
- Alza CorporationMountain View, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Skeletal muscle relaxant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLEXERIL | 00782742 | Cancelled Post Market |
Medicinal ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE 10 MG per TAB